Concepedia

Gautham Marigowda

GM

Statistics

Publications

21

Citations

8.2K

H-Index

20

Active since

2005

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Seattle Children's Hospital

University of Washington

University of Colorado Denver

University of Alabama at Birmingham

Gautham Marigowda is an author at Vertex Pharmaceuticals (United States) specializing in medicine, pulmonary fibrosis, and pulmonary medicine.

Top concepts

Publications per year

2005–2019

21

Publications

21

Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele

Peter G. Middleton, Marcus Mall, Pavel Dřevı́nek et al. · New England Journal of Medicine · 2019 · 2K citations · Full text

Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>

Claire Wainwright, J.S. Elborn, Bonnie W. Ramsey et al. · New England Journal of Medicine · 2015 · 1.6K citations · Full text

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

Harry Heijerman, Edward F. McKone, D.G. Downey et al. · The Lancet · 2019 · 1.3K citations · Full text

, , +2

VX-445–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles

D. Keating, Gautham Marigowda, Lucy Burr et al. · New England Journal of Medicine · 2018 · 707 citations · Full text

Active Albuterol or Placebo, Sham Acupuncture, or No Intervention in Asthma

Michael E. Wechsler, John M. Kelley, Ingrid O.E. Boyd et al. · New England Journal of Medicine · 2011 · 338 citations · Full text

1–5 of 21